Skip to main content
ENBIOCO., LTD. logo

ENBIOCO., LTD. — Investor Relations & Filings

Ticker · 352940 ISIN · KR7352940001 KO Water supply; sewerage, waste management and remediation activities
Open in API
Filings indexed 157 across all filing types
Latest filing 2022-03-16 Audit Report / Informat…
Country KR South Korea
Listing KO 352940

About ENBIOCO., LTD.

http://www.enbiotech.kr/index_en.html

ENBIOCO., LTD. is a technology company specializing in sustainable wastewater treatment and water recycling solutions. The company's core offering is its 'ZERO TECHNOLOGY,' a system designed to convert various types of wastewater into clean, reusable water. Its product line includes the 'ZERO TOILET,' a self-recycling flush toilet that operates without an external water supply or discharge connection, and the 'ZERO HOUSE,' a self-sufficient mobile home featuring an integrated wastewater recycling system. The company also develops specialized applications, such as the 'LIVESTOCK WASTEWATER ZERO SYSTEM' for pig farms and mobile treatment units for industrial and lifestyle wastewater. These solutions are engineered to provide green, self-sustaining water management.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report). It provides the audit opinion (unqualified/proper), key financial data (assets, liabilities, equity, profit/loss), and details about the external auditor (Samhwa Accounting Corp). While it contains financial data, it is a specific regulatory disclosure of the audit results rather than the full Annual Report (10-K) or a simple announcement of report publication (RPA). In the context of Korean regulatory filings (DART system), this is classified as an Audit Report filing. FY 2021
2022-03-16 Korean
전환가액의조정(제3회차)
Capital/Financing Update Classification · 100% confidence The document is a formal notice regarding the adjustment of the conversion price for convertible bonds (3rd series) due to a decline in market price. This type of filing, which details changes to the capital structure or financing terms (specifically conversion price adjustments), falls under the 'Capital/Financing Update' category.
2022-03-14 Korean
주주총회소집공고
AGM Information Classification · 100% confidence The document is a formal 'Notice of Annual General Meeting' (주주총회소집공고) for Enbio Co., Ltd. It includes the meeting agenda, date, location, and detailed financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, Cash Flow Statement) as part of the meeting materials provided to shareholders. Since this document contains the full set of materials and agenda for the AGM, it is classified as AGM Information.
2022-03-11 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Inbio) announcing a significant change in financial results (revenue or profit/loss structure exceeding 15-30%). It provides a summary table of financial performance (revenue, operating profit, net income) and explains the reasons for the variance. This is a standard periodic financial disclosure required by the Korea Exchange (KRX) for listed companies, which falls under the category of an Earnings Release (ER) as it provides the initial announcement of financial results highlights. FY 2021
2022-03-10 Korean
횡령ㆍ배임혐의발생
Legal Proceedings Report Classification · 100% confidence The document is a regulatory disclosure regarding the occurrence of embezzlement and breach of trust (legal proceedings) involving a former director. It details the filing of a criminal complaint and civil lawsuit. Since this document reports on significant legal matters and regulatory compliance issues rather than financial results or corporate governance reports, it falls under the 'Legal Proceedings Report' category.
2022-03-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details share transactions (buybacks/purchases) by a company executive (Lee Myeong-jae) of Enbio Co., Ltd. This type of filing is a standard regulatory requirement for reporting insider trading or changes in share ownership by directors and major shareholders, which corresponds to the 'Director's Dealing' category.
2022-03-03 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.